10 largest holdings as at 30 June 2014 (% of total investments)

Name Region Total
Roche Europe 6.4
HCA North America 3.8
Bristol-Myers Squibb North America 3.7
AbbVie North America 3.6
Mylan North America 3.6
Merck & Co North America 3.5
Regeneron Pharmaceuticals  North America 3.1
Amgen North America 3.0

Biogen Idec

North America 2.9
Actelion Europe 2.8
Total   36.4

All data in the above includes derivative, convertible bond or securitised debt exposures as an economically equivalent position in the underlying asset.

Sector, Geographical & Asset Class Breakdown at 31 June 2014

Large Caps 72.3% North America 73.7% Equities 91.5%
Small Caps 27.7% Europe 15.6% Derivatives 3.9%
Total 100.0% Emerging Markets 6.1% Convertible Bonds 3.5%
    Asia 4.6% Securitised Debt 1.1%
    Total 100.0% Total 100.0%